BDBM50176401 3-(2-chlorophenyl)-2-(4-chlorophenyl)-6-(2,2,2-trifluoroethyl)-2H-pyrazolo[4,3-d]pyrimidin-7(6H)-one::CHEMBL380937

SMILES: FC(F)(F)Cn1cnc2c(-c3ccccc3Cl)n(nc2c1=O)-c1ccc(Cl)cc1

InChI Key: InChIKey=TZMLQWOKHPFVET-UHFFFAOYSA-N

Data: 2 KI

Find this compound or compounds like it in BindingDB or PDB:

Substructure Similarity at least:  must be >=0.5 Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 50176401   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Cannabinoid receptor 1 (Homo sapiens (Human))	BDBM50176401 (3-(2-chlorophenyl)-2-(4-chlorophenyl)-6-(2,2,2-tri...) Show SMILES FC(F)(F)Cn1cnc2c(-c3ccccc3Cl)n(nc2c1=O)-c1ccc(Cl)cc1 |(32.92,3.31,;31.59,4.08,;32.37,5.41,;30.82,2.74,;30.26,4.85,;28.92,4.08,;27.59,4.86,;26.27,4.08,;26.26,2.55,;25.12,1.51,;23.61,1.82,;22.59,.68,;21.09,.99,;20.61,2.46,;21.63,3.61,;23.13,3.29,;24.16,4.43,;25.75,.11,;27.28,.27,;27.59,1.78,;28.92,2.54,;30.26,1.77,;24.99,-1.23,;23.45,-1.24,;22.68,-2.57,;23.45,-3.9,;22.69,-5.24,;25,-3.89,;25.76,-2.56,)| Show InChI InChI=1S/C19H11Cl2F3N4O/c20-11-5-7-12(8-6-11)28-17(13-3-1-2-4-14(13)21)15-16(26-28)18(29)27(10-25-15)9-19(22,23)24/h1-8,10H,9H2	PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	28	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Pfizer Global Research and Development-Groton Laboratories Curated by ChEMBL					Assay Description Displacement of [3H]SR141716 from human CB1 receptor transfected in HEK293 cells				Bioorg Med Chem Lett 16: 731-6 (2005) Article DOI: 10.1016/j.bmcl.2005.10.019 BindingDB Entry DOI: 10.7270/Q2TM79PM
					More data for this Ligand-Target Pair
Cannabinoid receptor 2 (Homo sapiens (Human))	BDBM50176401 (3-(2-chlorophenyl)-2-(4-chlorophenyl)-6-(2,2,2-tri...) Show SMILES FC(F)(F)Cn1cnc2c(-c3ccccc3Cl)n(nc2c1=O)-c1ccc(Cl)cc1 |(32.92,3.31,;31.59,4.08,;32.37,5.41,;30.82,2.74,;30.26,4.85,;28.92,4.08,;27.59,4.86,;26.27,4.08,;26.26,2.55,;25.12,1.51,;23.61,1.82,;22.59,.68,;21.09,.99,;20.61,2.46,;21.63,3.61,;23.13,3.29,;24.16,4.43,;25.75,.11,;27.28,.27,;27.59,1.78,;28.92,2.54,;30.26,1.77,;24.99,-1.23,;23.45,-1.24,;22.68,-2.57,;23.45,-3.9,;22.69,-5.24,;25,-3.89,;25.76,-2.56,)| Show InChI InChI=1S/C19H11Cl2F3N4O/c20-11-5-7-12(8-6-11)28-17(13-3-1-2-4-14(13)21)15-16(26-28)18(29)27(10-25-15)9-19(22,23)24/h1-8,10H,9H2	PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	>1.00E+4	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Pfizer Global Research and Development-Groton Laboratories Curated by ChEMBL					Assay Description Binding affinity to human CB2 receptor expressed in CHOK1 cells				Bioorg Med Chem Lett 16: 731-6 (2005) Article DOI: 10.1016/j.bmcl.2005.10.019 BindingDB Entry DOI: 10.7270/Q2TM79PM
					More data for this Ligand-Target Pair